Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis

被引:23
作者
Kamarajah, Sivesh K. [1 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England
关键词
resection; liver; HCC; outcomes; fibrosis; CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; SURGICAL RESECTION; HEPATIC RESECTION; ANTIVIRAL THERAPY; MILAN CRITERIA; MANAGEMENT; HEPATECTOMY; VALIDATION; PROGNOSIS;
D O I
10.1016/j.asjsur.2018.01.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background/Objectives: Surgical extirpation for hepatocellular carcinoma (HCC) with background fibrosis remains a challenge. This study evaluated impact of fibrosis score on long term outcomes of patients undergoing surgical resection for HCC. Methods: Using the Surveillance, Epidemiology and End Results (SEER) database (2004-2013), complete data on 1433 patients undergoing surgical resection for non-metastatic HCC were identified. Overall survival (OS) was estimated using the Kaplan-Meier method. Cox proportional hazards model were used to produce adjusted hazard ratios (HR). Results: In this study, 54% (650/1433) patients had F5-6 fibrosis at the time for surgical resection of HCC. In adjusted models, F5/6 fibrosis significantly reduces overall survival (HR: 1.62, 95% CI: 1.34-1.94; p < 0.001). Median survival was significantly longer for patients with F0-4 fibrosis for T1a, T1b and T2 tumours as compared to F5-6 fibrosis, not for T3 and T4 tumours, even when stratified by extent of hepatectomy. There were no significant differences in 90-day post-operative mortality between fibrosis groups when stratified by T-classifications. Conclusion: Liver resection in patients with advanced fibrosis has significantly lower survival as compared to patients with F0-4 fibrosis in early stage (T1 and T2), not advanced tumours (T3 and T4). Improvement in patient selection and perioperative care for liver resection may offer consistent and clinically meaningful long-term survival in HCC. (C) 2018 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.
引用
收藏
页码:551 / 561
页数:11
相关论文
共 37 条
[31]   Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma [J].
Wang, Q. ;
Fiel, M. I. ;
Blank, S. ;
Luan, W. ;
Kadri, H. ;
Kim, K. W. ;
Manizate, F. ;
Rosenblatt, A. G. ;
Labow, D. M. ;
Schwartz, M. E. ;
Hiotis, S. P. .
BRITISH JOURNAL OF CANCER, 2013, 109 (03) :573-581
[32]   Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C [J].
Wei, Qin ;
Tian, Huan ;
Luo, Huan-xian ;
Zhang, Ying-cai ;
Deng, Yi-nan ;
Yao, Jia ;
Li, Hua ;
Chen, Gui-hua ;
Yang, Yang .
ASIAN JOURNAL OF SURGERY, 2017, 40 (06) :453-462
[33]   Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging [J].
Yao, F. Y. ;
Xiao, L. ;
Bass, N. M. ;
Kerlan, R. ;
Ascher, N. L. ;
Roberts, J. P. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (11) :2587-2596
[34]   Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival [J].
Yao, FY ;
Ferrell, L ;
Bass, NM ;
Watson, JJ ;
Bacchetti, P ;
Venook, A ;
Ascher, NL ;
Roberts, JP .
HEPATOLOGY, 2001, 33 (06) :1394-1403
[35]   Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma [J].
Yau, Thomas ;
Tang, Vikki Y. F. ;
Yao, Tzy-Jyun ;
Fan, Sheung-Tat ;
Lo, Chung-Mau ;
Poon, Ronnie T. P. .
GASTROENTEROLOGY, 2014, 146 (07) :1691-+
[36]   Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma [J].
Zhong, Jian-hong ;
Ke, Yang ;
Gong, Wen-feng ;
Xiang, Bang-de ;
Ma, Liang ;
Ye, Xin-ping ;
Peng, Tao ;
Xie, Gui-sheng ;
Li, Le-qun .
ANNALS OF SURGERY, 2014, 260 (02) :329-340
[37]  
Zhu SL, 2015, INT J CLIN EXP MED, V8, P20581